Genipin derivative having anti hepatitis B virus activity
US6162826A · kind A · utility
9Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 1999 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Apr 14, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a novel genipin derivative represented by formula (I), which has anti hepatitis B virus (HBV) activity, in which R.sub.1 represents lower alkyl, benzyl, etc., R.sub.2 represents hydroxymethyl, formyl, acetyl, etc., R.sub.3 represents methoxycarbonyl, formyl, etc., its pharmaceutically acceptable salt, and stereoisomer. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.